Publications by authors named "Yuval Harris"

Drug combination therapy is a main pillar of cancer therapy. As the number of possible drug candidates for combinations grows, the development of optimal high complexity combination therapies (involving 4 or more drugs per treatment) such as RCHOP-I and FOLFIRINOX becomes increasingly challenging due to combinatorial explosion. In this paper, we propose a text mining (TM) based tool and workflow for rapid generation of high complexity combination treatments (HCCT) in order to extend the boundaries of complexity in cancer treatments.

View Article and Find Full Text PDF
Article Synopsis
  • Combination therapy is popular in cancer treatment for its ability to enhance drug effectiveness and limit resistance, leading to the development of nanomedicines that reduce toxicity.
  • Researchers analyzed the self-assembly of 77 drugs with the near-infrared dye IR783, discovering that only a small fraction of drugs can form stable nanoparticles.
  • A machine learning model was created to predict self-assembly outcomes and helped identify effective cancer drug pairs, including a new combination of bortezomib and cabozantinib, which demonstrated better efficacy and reduced toxicity in head and neck cancer.
View Article and Find Full Text PDF

Polydopamine (PDA), a biomaterial inspired by marine mussels, has attracted interest in cancer nanomedicine due to its photothermal properties, nanoparticle coating, and pi-pi stacking-based drug encapsulation abilities. Despite numerous one-pot and post-polymerization modifications, PDA copolymers have not been sufficiently studied in the context of stabilizing hydrophobic drugs in the process of nanoprecipitation. In this study, we tested combinatorial panels of comonomers with PDA to optimize drug loading efficiency, particle size and stability of nano formulations made via drug nanoprecipitation.

View Article and Find Full Text PDF

Nanoformulations of small molecule drugs are essential to effectively deliver them and treat a wide range of diseases. They are normally complex to develop, lack predictability, and exhibit low drug loading. Recently, nanoparticles made via co-assembly of hydrophobic drugs and organic dyes, exhibited drug-loading of up to 90% with high predictability from the drug structure.

View Article and Find Full Text PDF